Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beam Therapeutics (BEAM) Assets Average (2020 - 2025)

Beam Therapeutics (BEAM) has disclosed Assets Average for 6 consecutive years, with $1.4 billion as the latest value for Q4 2025.

  • Quarterly Assets Average rose 22.73% to $1.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Dec 2025, up 22.73% year-over-year, with the annual reading at $1.3 billion for FY2025, 0.84% up from the prior year.
  • Assets Average for Q4 2025 was $1.4 billion at Beam Therapeutics, up from $1.4 billion in the prior quarter.
  • The five-year high for Assets Average was $1.5 billion in Q1 2022, with the low at $572.5 million in Q1 2021.
  • Average Assets Average over 5 years is $1.3 billion, with a median of $1.3 billion recorded in 2023.
  • The sharpest move saw Assets Average soared 260.44% in 2021, then fell 17.27% in 2024.
  • Over 5 years, Assets Average stood at $1.3 billion in 2021, then grew by 2.32% to $1.3 billion in 2022, then increased by 2.17% to $1.4 billion in 2023, then dropped by 17.27% to $1.1 billion in 2024, then rose by 22.73% to $1.4 billion in 2025.
  • According to Business Quant data, Assets Average over the past three periods came in at $1.4 billion, $1.4 billion, and $1.4 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.